<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d6" origId="Acitretin"><sentence id="DrugDDI.d6.s0" origId="s0" text="Ethanol:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol."><entity id="DrugDDI.d6.s0.e0" origId="s0.p0" charOffset="0-7" type="drug" text="Ethanol"/><entity id="DrugDDI.d6.s0.e1" origId="s0.p5" charOffset="41-51" type="drug" text="etretinate"/><entity id="DrugDDI.d6.s0.e2" origId="s0.p10" charOffset="95-104" type="drug" text="acitretin"/><entity id="DrugDDI.d6.s0.e3" origId="s0.p12" charOffset="109-116" type="drug" text="ethanol"/><pair id="DrugDDI.d6.s0.p0" e1="DrugDDI.d6.s0.e0" e2="DrugDDI.d6.s0.e1" interaction="false"/><pair id="DrugDDI.d6.s0.p1" e1="DrugDDI.d6.s0.e0" e2="DrugDDI.d6.s0.e2" interaction="false"/><pair id="DrugDDI.d6.s0.p2" e1="DrugDDI.d6.s0.e0" e2="DrugDDI.d6.s0.e3" interaction="false"/><pair id="DrugDDI.d6.s0.p3" e1="DrugDDI.d6.s0.e1" e2="DrugDDI.d6.s0.e2" interaction="false"/><pair id="DrugDDI.d6.s0.p4" e1="DrugDDI.d6.s0.e1" e2="DrugDDI.d6.s0.e3" interaction="false"/><pair id="DrugDDI.d6.s0.p5" e1="DrugDDI.d6.s0.e2" e2="DrugDDI.d6.s0.e3" interaction="true"/></sentence><sentence id="DrugDDI.d6.s1" origId="s1" text="Glibenclamide: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects."><entity id="DrugDDI.d6.s1.e0" origId="s1.p13" charOffset="0-13" type="drug" text="Glibenclamide"/><entity id="DrugDDI.d6.s1.e1" origId="s1.p17" charOffset="56-65" type="drug" text="acitretin"/><entity id="DrugDDI.d6.s1.e2" origId="s1.p20" charOffset="125-138" type="drug" text="glibenclamide"/><entity id="DrugDDI.d6.s1.e3" origId="s1.p22" charOffset="142-154" type="drug" text="sulfonylurea"/><entity id="DrugDDI.d6.s1.e4" origId="s1.p23" charOffset="166-180" type="drug" text="chlorpropamide"/><pair id="DrugDDI.d6.s1.p0" e1="DrugDDI.d6.s1.e0" e2="DrugDDI.d6.s1.e1" interaction="false"/><pair id="DrugDDI.d6.s1.p1" e1="DrugDDI.d6.s1.e0" e2="DrugDDI.d6.s1.e2" interaction="false"/><pair id="DrugDDI.d6.s1.p2" e1="DrugDDI.d6.s1.e0" e2="DrugDDI.d6.s1.e3" interaction="false"/><pair id="DrugDDI.d6.s1.p3" e1="DrugDDI.d6.s1.e0" e2="DrugDDI.d6.s1.e4" interaction="false"/><pair id="DrugDDI.d6.s1.p4" e1="DrugDDI.d6.s1.e1" e2="DrugDDI.d6.s1.e2" interaction="true"/><pair id="DrugDDI.d6.s1.p5" e1="DrugDDI.d6.s1.e1" e2="DrugDDI.d6.s1.e3" interaction="false"/><pair id="DrugDDI.d6.s1.p6" e1="DrugDDI.d6.s1.e1" e2="DrugDDI.d6.s1.e4" interaction="false"/><pair id="DrugDDI.d6.s1.p7" e1="DrugDDI.d6.s1.e2" e2="DrugDDI.d6.s1.e3" interaction="false"/><pair id="DrugDDI.d6.s1.p8" e1="DrugDDI.d6.s1.e2" e2="DrugDDI.d6.s1.e4" interaction="false"/><pair id="DrugDDI.d6.s1.p9" e1="DrugDDI.d6.s1.e3" e2="DrugDDI.d6.s1.e4" interaction="false"/></sentence><sentence id="DrugDDI.d6.s2" origId="s2" text="Repeating the study with 6 healthy male volunteers in the absence of glibenclamide did not detect an effect of acitretin on glucose tolerance."><entity id="DrugDDI.d6.s2.e0" origId="s2.p31" charOffset="69-82" type="drug" text="glibenclamide"/><entity id="DrugDDI.d6.s2.e1" origId="s2.p36" charOffset="111-120" type="drug" text="acitretin"/><pair id="DrugDDI.d6.s2.p0" e1="DrugDDI.d6.s2.e0" e2="DrugDDI.d6.s2.e1" interaction="false"/></sentence><sentence id="DrugDDI.d6.s3" origId="s3" text="Careful supervision of diabetic patients under treatment with Soriatane is recommended."><entity id="DrugDDI.d6.s3.e0" origId="s3.p41" charOffset="62-71" type="drug" text="Soriatane"/></sentence><sentence id="DrugDDI.d6.s4" origId="s4" text="Hormonal Contraceptives: It has not been established if there is a pharmacokinetic interaction between acitretin and combined oral contraceptives."><entity id="DrugDDI.d6.s4.e0" origId="s4.p44" charOffset="9-23" type="drug" text="Contraceptives"/><entity id="DrugDDI.d6.s4.e1" origId="s4.p54" charOffset="103-112" type="drug" text="acitretin"/><entity id="DrugDDI.d6.s4.e2" origId="s4.p56" charOffset="117-145" type="drug" text="combined oral contraceptives"/><pair id="DrugDDI.d6.s4.p0" e1="DrugDDI.d6.s4.e0" e2="DrugDDI.d6.s4.e1" interaction="false"/><pair id="DrugDDI.d6.s4.p1" e1="DrugDDI.d6.s4.e0" e2="DrugDDI.d6.s4.e2" interaction="false"/><pair id="DrugDDI.d6.s4.p2" e1="DrugDDI.d6.s4.e1" e2="DrugDDI.d6.s4.e2" interaction="false"/></sentence><sentence id="DrugDDI.d6.s5" origId="s5" text="However, it has been established that acitretin interferes with the contraceptive effect of microdosed progestin minipill preparations."><entity id="DrugDDI.d6.s5.e0" origId="s5.p62" charOffset="38-47" type="drug" text="acitretin"/><entity id="DrugDDI.d6.s5.e1" origId="s5.p64" charOffset="68-81" type="drug" text="contraceptive"/><entity id="DrugDDI.d6.s5.e2" origId="s5.p65" charOffset="92-134" type="drug" text="microdosed progestin minipill preparations"/><pair id="DrugDDI.d6.s5.p0" e1="DrugDDI.d6.s5.e0" e2="DrugDDI.d6.s5.e1" interaction="false"/><pair id="DrugDDI.d6.s5.p1" e1="DrugDDI.d6.s5.e0" e2="DrugDDI.d6.s5.e2" interaction="true"/><pair id="DrugDDI.d6.s5.p2" e1="DrugDDI.d6.s5.e1" e2="DrugDDI.d6.s5.e2" interaction="false"/></sentence><sentence id="DrugDDI.d6.s6" origId="s6" text="Microdosed minipill progestin preparations are not recommended for use with Soriatane."><entity id="DrugDDI.d6.s6.e0" origId="s6.p66" charOffset="20-42" type="drug" text="progestin preparations"/><entity id="DrugDDI.d6.s6.e1" origId="s6.p71" charOffset="76-85" type="drug" text="Soriatane"/><pair id="DrugDDI.d6.s6.p0" e1="DrugDDI.d6.s6.e0" e2="DrugDDI.d6.s6.e1" interaction="true"/></sentence><sentence id="DrugDDI.d6.s7" origId="s7" text="It is not known whether other progestational contraceptives, such as implants and injectables, are adequate methods of contraception during acitretin therapy."><entity id="DrugDDI.d6.s7.e0" origId="s7.p76" charOffset="45-59" type="drug" text="contraceptives"/><entity id="DrugDDI.d6.s7.e1" origId="s7.p83" charOffset="140-149" type="drug" text="acitretin"/><pair id="DrugDDI.d6.s7.p0" e1="DrugDDI.d6.s7.e0" e2="DrugDDI.d6.s7.e1" interaction="false"/></sentence><sentence id="DrugDDI.d6.s8" origId="s8" text="Methotrexate: An increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate."><entity id="DrugDDI.d6.s8.e0" origId="s8.p84" charOffset="0-12" type="drug" text="Methotrexate"/><entity id="DrugDDI.d6.s8.e1" origId="s8.p94" charOffset="94-106" type="drug" text="methotrexate"/><entity id="DrugDDI.d6.s8.e2" origId="s8.p96" charOffset="111-121" type="drug" text="etretinate"/><pair id="DrugDDI.d6.s8.p0" e1="DrugDDI.d6.s8.e0" e2="DrugDDI.d6.s8.e1" interaction="false"/><pair id="DrugDDI.d6.s8.p1" e1="DrugDDI.d6.s8.e0" e2="DrugDDI.d6.s8.e2" interaction="false"/><pair id="DrugDDI.d6.s8.p2" e1="DrugDDI.d6.s8.e1" e2="DrugDDI.d6.s8.e2" interaction="true"/></sentence><sentence id="DrugDDI.d6.s9" origId="s9" text="Consequently, the combination of methotrexate with acitretin is also contraindicated."><entity id="DrugDDI.d6.s9.e0" origId="s9.p99" charOffset="33-45" type="drug" text="methotrexate"/><entity id="DrugDDI.d6.s9.e1" origId="s9.p100" charOffset="51-60" type="drug" text="acitretin"/><pair id="DrugDDI.d6.s9.p0" e1="DrugDDI.d6.s9.e0" e2="DrugDDI.d6.s9.e1" interaction="true"/></sentence><sentence id="DrugDDI.d6.s10" origId="s10" text="Phenytoin: If acitretin is given concurrently with phenytoin, the protein binding of phenytoin may be reduced."><entity id="DrugDDI.d6.s10.e0" origId="s10.p104" charOffset="0-9" type="drug" text="Phenytoin"/><entity id="DrugDDI.d6.s10.e1" origId="s10.p106" charOffset="14-23" type="drug" text="acitretin"/><entity id="DrugDDI.d6.s10.e2" origId="s10.p110" charOffset="51-60" type="drug" text="phenytoin"/><entity id="DrugDDI.d6.s10.e3" origId="s10.p112" charOffset="85-94" type="drug" text="phenytoin"/><pair id="DrugDDI.d6.s10.p0" e1="DrugDDI.d6.s10.e0" e2="DrugDDI.d6.s10.e1" interaction="false"/><pair id="DrugDDI.d6.s10.p1" e1="DrugDDI.d6.s10.e0" e2="DrugDDI.d6.s10.e2" interaction="false"/><pair id="DrugDDI.d6.s10.p2" e1="DrugDDI.d6.s10.e0" e2="DrugDDI.d6.s10.e3" interaction="false"/><pair id="DrugDDI.d6.s10.p3" e1="DrugDDI.d6.s10.e1" e2="DrugDDI.d6.s10.e2" interaction="true"/><pair id="DrugDDI.d6.s10.p4" e1="DrugDDI.d6.s10.e1" e2="DrugDDI.d6.s10.e3" interaction="false"/><pair id="DrugDDI.d6.s10.p5" e1="DrugDDI.d6.s10.e2" e2="DrugDDI.d6.s10.e3" interaction="false"/></sentence><sentence id="DrugDDI.d6.s11" origId="s11" text="Tetracyclines: Since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated."><entity id="DrugDDI.d6.s11.e0" origId="s11.p116" charOffset="0-13" type="drug" text="Tetracyclines"/><entity id="DrugDDI.d6.s11.e1" origId="s11.p120" charOffset="26-35" type="drug" text="acitretin"/><entity id="DrugDDI.d6.s11.e2" origId="s11.p122" charOffset="40-53" type="drug" text="tetracyclines"/><pair id="DrugDDI.d6.s11.p0" e1="DrugDDI.d6.s11.e0" e2="DrugDDI.d6.s11.e1" interaction="false"/><pair id="DrugDDI.d6.s11.p1" e1="DrugDDI.d6.s11.e0" e2="DrugDDI.d6.s11.e2" interaction="false"/><pair id="DrugDDI.d6.s11.p2" e1="DrugDDI.d6.s11.e1" e2="DrugDDI.d6.s11.e2" interaction="true"/></sentence><sentence id="DrugDDI.d6.s12" origId="s12" text="Vitamin A and oral retinoids: Concomitant administration of vitamin A and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis A."><entity id="DrugDDI.d6.s12.e0" origId="s12.p129" charOffset="0-9" type="drug" text="Vitamin A"/><entity id="DrugDDI.d6.s12.e1" origId="s12.p131" charOffset="19-28" type="drug" text="retinoids"/><entity id="DrugDDI.d6.s12.e2" origId="s12.p134" charOffset="60-69" type="drug" text="vitamin A"/><entity id="DrugDDI.d6.s12.e3" origId="s12.p136" charOffset="88-97" type="drug" text="retinoids"/><entity id="DrugDDI.d6.s12.e4" origId="s12.p137" charOffset="103-112" type="drug" text="acitretin"/><pair id="DrugDDI.d6.s12.p0" e1="DrugDDI.d6.s12.e0" e2="DrugDDI.d6.s12.e1" interaction="false"/><pair id="DrugDDI.d6.s12.p1" e1="DrugDDI.d6.s12.e0" e2="DrugDDI.d6.s12.e2" interaction="false"/><pair id="DrugDDI.d6.s12.p2" e1="DrugDDI.d6.s12.e0" e2="DrugDDI.d6.s12.e3" interaction="false"/><pair id="DrugDDI.d6.s12.p3" e1="DrugDDI.d6.s12.e0" e2="DrugDDI.d6.s12.e4" interaction="false"/><pair id="DrugDDI.d6.s12.p4" e1="DrugDDI.d6.s12.e1" e2="DrugDDI.d6.s12.e2" interaction="false"/><pair id="DrugDDI.d6.s12.p5" e1="DrugDDI.d6.s12.e1" e2="DrugDDI.d6.s12.e3" interaction="false"/><pair id="DrugDDI.d6.s12.p6" e1="DrugDDI.d6.s12.e1" e2="DrugDDI.d6.s12.e4" interaction="false"/><pair id="DrugDDI.d6.s12.p7" e1="DrugDDI.d6.s12.e2" e2="DrugDDI.d6.s12.e3" interaction="false"/><pair id="DrugDDI.d6.s12.p8" e1="DrugDDI.d6.s12.e2" e2="DrugDDI.d6.s12.e4" interaction="true"/><pair id="DrugDDI.d6.s12.p9" e1="DrugDDI.d6.s12.e3" e2="DrugDDI.d6.s12.e4" interaction="false"/></sentence><sentence id="DrugDDI.d6.s13" origId="s13" text="Other: There appears to be no pharmacokinetic interaction between acitretin and cimetidine, digoxin, or glyburide."><entity id="DrugDDI.d6.s13.e0" origId="s13.p150" charOffset="66-75" type="drug" text="acitretin"/><entity id="DrugDDI.d6.s13.e1" origId="s13.p152" charOffset="80-90" type="drug" text="cimetidine"/><entity id="DrugDDI.d6.s13.e2" origId="s13.p153" charOffset="92-99" type="drug" text="digoxin"/><entity id="DrugDDI.d6.s13.e3" origId="s13.p155" charOffset="104-113" type="drug" text="glyburide"/><pair id="DrugDDI.d6.s13.p0" e1="DrugDDI.d6.s13.e0" e2="DrugDDI.d6.s13.e1" interaction="false"/><pair id="DrugDDI.d6.s13.p1" e1="DrugDDI.d6.s13.e0" e2="DrugDDI.d6.s13.e2" interaction="false"/><pair id="DrugDDI.d6.s13.p2" e1="DrugDDI.d6.s13.e0" e2="DrugDDI.d6.s13.e3" interaction="false"/><pair id="DrugDDI.d6.s13.p3" e1="DrugDDI.d6.s13.e1" e2="DrugDDI.d6.s13.e2" interaction="false"/><pair id="DrugDDI.d6.s13.p4" e1="DrugDDI.d6.s13.e1" e2="DrugDDI.d6.s13.e3" interaction="false"/><pair id="DrugDDI.d6.s13.p5" e1="DrugDDI.d6.s13.e2" e2="DrugDDI.d6.s13.e3" interaction="false"/></sentence><sentence id="DrugDDI.d6.s14" origId="s14" text="Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction."><entity id="DrugDDI.d6.s14.e0" origId="s14.p158" charOffset="34-43" type="drug" text="acitretin"/><entity id="DrugDDI.d6.s14.e1" origId="s14.p160" charOffset="70-84" type="drug" text="anticoagulants"/><entity id="DrugDDI.d6.s14.e2" origId="s14.p161" charOffset="92-100" type="drug" text="coumarin"/><entity id="DrugDDI.d6.s14.e3" origId="s14.p163" charOffset="107-115" type="drug" text="warfarin"/><pair id="DrugDDI.d6.s14.p0" e1="DrugDDI.d6.s14.e0" e2="DrugDDI.d6.s14.e1" interaction="false"/><pair id="DrugDDI.d6.s14.p1" e1="DrugDDI.d6.s14.e0" e2="DrugDDI.d6.s14.e2" interaction="false"/><pair id="DrugDDI.d6.s14.p2" e1="DrugDDI.d6.s14.e0" e2="DrugDDI.d6.s14.e3" interaction="false"/><pair id="DrugDDI.d6.s14.p3" e1="DrugDDI.d6.s14.e1" e2="DrugDDI.d6.s14.e2" interaction="false"/><pair id="DrugDDI.d6.s14.p4" e1="DrugDDI.d6.s14.e1" e2="DrugDDI.d6.s14.e3" interaction="false"/><pair id="DrugDDI.d6.s14.p5" e1="DrugDDI.d6.s14.e2" e2="DrugDDI.d6.s14.e3" interaction="false"/></sentence><sentence id="DrugDDI.d6.s15" origId="s15" text="Laboratory Tests If significant abnormal laboratory results are obtained, either dosage reduction with careful monitoring or treatment discontinuation is recommended, depending on clinical judgement."/><sentence id="DrugDDI.d6.s16" origId="s16" text="Blood Sugar: Some patients receiving retinoids have experienced problems with blood sugar control."><entity id="DrugDDI.d6.s16.e0" origId="s16.p186" charOffset="37-46" type="drug" text="retinoids"/></sentence><sentence id="DrugDDI.d6.s17" origId="s17" text="In addition, new cases of diabetes have been diagnosed during retinoid therapy, including diabetic ketoacidosis."><entity id="DrugDDI.d6.s17.e0" origId="s17.p196" charOffset="62-70" type="drug" text="retinoid"/></sentence><sentence id="DrugDDI.d6.s18" origId="s18" text="In diabetics, blood-sugar levels should be monitored very carefully."/><sentence id="DrugDDI.d6.s19" origId="s19" text="Lipids: In clinical studies, the incidence of hypertriglyceridemia was 66%, hypercholesterolemia was 33% and that of decreased HDL was 40%."/><sentence id="DrugDDI.d6.s20" origId="s20" text="Pretreatment and follow-up measurements should be obtained under fasting conditions."/><sentence id="DrugDDI.d6.s21" origId="s21" text="It is recommended that these tests be performed weekly or every other week until the lipid response to Soriatane has stabilized."><entity id="DrugDDI.d6.s21.e0" origId="s21.p237" charOffset="103-112" type="drug" text="Soriatane"/></sentence><sentence id="DrugDDI.d6.s22" origId="s22" text="Liver Function Tests: Elevations of AST (SGOT), ALT (SGPT) or LDH were experienced by approximately 1 in 3 patients treated with Soriatane."><entity id="DrugDDI.d6.s22.e0" origId="s22.p243" charOffset="36-39" type="drug" text="AST"/><entity id="DrugDDI.d6.s22.e1" origId="s22.p253" charOffset="62-65" type="drug" text="LDH"/><entity id="DrugDDI.d6.s22.e2" origId="s22.p259" charOffset="129-138" type="drug" text="Soriatane"/><pair id="DrugDDI.d6.s22.p0" e1="DrugDDI.d6.s22.e0" e2="DrugDDI.d6.s22.e1" interaction="false"/><pair id="DrugDDI.d6.s22.p1" e1="DrugDDI.d6.s22.e0" e2="DrugDDI.d6.s22.e2" interaction="true"/><pair id="DrugDDI.d6.s22.p2" e1="DrugDDI.d6.s22.e1" e2="DrugDDI.d6.s22.e2" interaction="false"/></sentence><sentence id="DrugDDI.d6.s23" origId="s23" text="It is recommended that these tests be performed prior to initiation of Soriatane therapy, at 1- to 2-week intervals until stable and thereafter at intervals as clinically indicated."><entity id="DrugDDI.d6.s23.e0" origId="s23.p267" charOffset="71-80" type="drug" text="Soriatane"/></sentence></document>